Design, Synthesis and In-Vitro Evaluation of Polymer-linked Prodrug of Methotrexate for the Targeted Delivery to the Colon

Author(s): Nishu Singla, Rajiv Sharma, T.R. Bhardwaj.

Journal Name: Letters in Drug Design & Discovery

Volume 11 , Issue 5 , 2014

Become EABM
Become Reviewer


The different substituted polyphosphazene-linked azo prodrug of Methotrexate (9-12) and chitosan-linked azo prodrug of methotrexate (13) were synthesized and characterized by modern analytical techniques such as IR, 1H NMR, 31P NMR and GPC. The in-vitro stability study showed that all polymeric drug conjugates are stable in upper GIT (pH = 1.2) and small intestine (pH = 7.4). In-vitro drug release showed that polyphosphazene-linked azo prodrug of methotrexate (12) has maximum release (88.4%) in the presence of rat cecal content compared to chitosan linked azo prodrug of methotrexate (13). Therefore, the synthesized polyphosphazene linked azo based drug conjugates of methotrexate (9-12) are the potential candidates for colon targeted drug delivery system with minimal undesirable side effects.

Keywords: Cancer, Chitosan, Drug conjugate, Polyphosphazene, Polymer, Prodrug.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [601 - 610]
Pages: 10
DOI: 10.2174/1570180811666131217002719
Price: $65

Article Metrics

PDF: 17